Covestor’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-11
| Closed | – | – | 2510 |
|
|
2025
Q2 | $0 | Buy |
11
+5
| +83% | +$40 | ﹤0.01% | 2463 |
|
|
2025
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 2470 |
|
|
2024
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 2479 |
|
|
2024
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 2460 |
|
|
2024
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 2479 |
|
|
2024
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 2477 |
|
|
2023
Q4 | $0 | Sell |
6
-1
| -14% | -$10 | ﹤0.01% | 2401 |
|
|
2023
Q3 | $0 | Buy |
7
+3
| +75% | +$38 | ﹤0.01% | 2389 |
|
|
2023
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 2380 |
|
|
2023
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 2289 |
|
|
2022
Q4 | $0 | Sell |
4
-1
| -20% | -$20 | ﹤0.01% | 2313 |
|
|
2022
Q3 | $0 | Sell |
5
-141
| -97% | -$3.25K | ﹤0.01% | 2276 |
|
|
2022
Q2 | $3K | Buy |
146
+130
| +813% | +$3.08K | ﹤0.01% | 1526 |
|
|
2022
Q1 | $1K | Buy |
+16
| New | +$581 | ﹤0.01% | 1856 |
|
Other funds holding ITOS
Covestor's ITOS Position: Q3 2025 in Review
Covestor sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 11 shares.
Covestor first reported a position in ITOS in Q1 2022 and held it in 14 quarters. The position peaked at $3K in Q2 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Covestor reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Covestor sold 11 iTeos Therapeutics shares in Q3 2025.
- Covestor first reported a position in iTeos Therapeutics in Q1 2022 and held it in 14 quarters.
- Covestor's iTeos Therapeutics position peaked at $3K in Q2 2022.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.